ATM induction insufficiency in a radiosensitive breast-cancer patient

R A Clarke1, Z H Fang, P J Marr

  • 1Molecular Genetics Laboratories, Cancer Care Center, Division of Cancer Services, The St George Hospital and University of New South Wales, Australia. r.clarke@unsw.edu.au

Australasian Radiology
|August 28, 2002
PubMed

Insights

Ataxia telangiectasia (ATM) gene mutations increase breast cancer risk. This study found significantly lower ATM protein levels in a radiosensitive breast cancer patient, suggesting broader ATM roles in cancer.

Area of Science:

  • Oncology
  • Genetics
  • Molecular Biology

Background:

  • The ATM gene is a known tumor suppressor and dominant breast cancer gene.
  • ATM regulates cellular sensitivity to ionizing radiation (IR) via DNA repair.
  • ATM protein levels and kinase activity increase rapidly upon IR exposure in normal cells.

Observation:

  • This report details ATM protein downregulation in a radiosensitive breast cancer patient.
  • Post-induction ATM levels were up to tenfold lower in the patient's fresh tissues compared to normal controls.

Findings:

  • ATM protein levels were significantly reduced in the breast cancer patient's tissues.
  • This downregulation was observed even after IR induction.

Implications:

  • ATM anomalies may play a broader role in breast cancer etiology.
  • Reduced ATM levels could contribute to radiosensitivity and cancer development.
  • Further research into ATM's tumor suppressor function in breast cancer is warranted.

Related Concept Videos